Dolly B. Tyan, PhD

Publications

• Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Norman PJ, Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, Rowley D, Bruno D, Carrington CV, Chandanayingyong D, Chang YH, Crespí C, Saruhan-Direskeneli G, Fraser PA, Hameed K, Kamkamidze G, Koram KA, Layrisse Z, Matamoros N, Milà J, Park MH, Pitchappan RM, Ramdath DD, Shiau MY, Stephens HA, Struik S, Verity DH, Vaughan RW, Tyan D, Davis RW, Riley EM, Ronaghi M, Parham P. Nat Genet. 2007; 39 (9): 1092-9
• Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P. J Immunol. 2002; 168 (5): 2307-15
• Genetic control of human NK cell repertoire. Shilling HG, Young N, Guethlein LA, Cheng NW, Gardiner CM, Tyan D, Parham P. J Immunol. 2002; 169 (1): 239-47
• Human diversity in killer cell inhibitory receptor genes. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P. Immunity. 1997; 7 (6): 753-63
• Cw*1701 defines a divergent african HLA-C allelic lineage. Wells RS, Seielstad MT, Bunce M, Tyan DB, Bekele E, Parham P. Immunogenetics. 1997; 46 (3): 173-80
• Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype. Gumperz JE, Valiante NM, Parham P, Lanier LL, Tyan D. J Exp Med. 1996; 183 (4): 1817-27
• HLA-B16 antigens: sequence of the ST-16 antigen, further definition of two B38 subtypes and evidence for convergent evolution of B*3902. Adams EJ, Martinez-Naves E, Arnett KL, Little AM, Tyan DB, Parham P. Tissue Antigens. 1995; 45 (1): 18-26
• Use of RecA protein to enrich for homologous genes in a genomic library. Taidi-Laskowski B, Tyan D, Honigberg SM, Radding CR, Grumet FC. Nucleic Acids Res. 1988; 16 (16): 8157-69